Introduction
============

As the leading cause of death in Korea \[[@b1-crt-2019-139]\], cancer has been the country's major public health concern since 1983. Over 220,000 patients were newly diagnosed with cancer in Korea, and one in four deaths is due to cancer \[[@b2-crt-2019-139]\]. Although the cancer registration system in Korea is highly efficient and can provide nationwide cancer statistics within a relatively short period, a lag time of at least 2 years is required to collect and analyze data on a specific year. For planning and implementation of comprehensive cancer control programs, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this study, we report the projected cancer incidence and mortality for the year 2019 based on data from the 1990s through to 2017.

Materials and Methods
=====================

The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry, the Korea Central Cancer Registry (KCCR), in 1980. The history, objectives, and activities of the KCCR have been documented in detail elsewhere \[[@b3-crt-2019-139]\]. Incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database (KNCI DB). Cancer cases were classified according to the International Classification of Diseases for Oncology, third edition \[[@b4-crt-2019-139]\], and converted according to the International Classification of Diseases, 10th edition (ICD-10) \[[@b5-crt-2019-139]\]. Mortality data from 1993 to 2017 were acquired from Statistics Korea \[[@b1-crt-2019-139]\]. The cause of death was coded and classified according to ICD-10 \[[@b5-crt-2019-139]\].

The cancer sites included in this study were (1) all cancers sites combined and (2) the 24 common cancer sites as follows: lips, oral cavity, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of the biliary tract (gallbladder) (C23-C24), pancreas (C25), larynx (C32), trachea, bronchus and lung (lung) (C33-C34), breast (C50), cervix uteri (C53), corpus uteri (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C86, C96), multiple myeloma (C90), leukemia (C91-C95), and 'other and ill defined' sites.

Population data from 1993 to 2019 were obtained from the resident registration population data, reported by Statistics Korea. Data on the mid-year population, as of July 1 of the respective year, were analyzed. However, we used population data as of December 31, 2018 for the year 2019, because mid-2019 resident registration population data were not yet available at the time of analysis.

Linear regression models \[[@b6-crt-2019-139]\] were used to assess time trends and projections. We first performed a *Joinpoint* regression analysis on the data available to detect the year when significant changes occurred in cancer trends according to sex and cancer site. A *Joinpoint* regression describes changes in data trends by connecting several different line segments on a log scale at "joinpoints." This analysis was performed using the *Joinpoint* software (ver. 4.3.1, <http://surveillance.cancer.gov/joinpoint>) from the Surveillance Research Program of the US National Cancer Institute \[[@b7-crt-2019-139]\]. For the analysis, we arranged to have at least four data points between consecutive joinpoints. Secondly, to predict age-specific cancer rates, a linear regression model was fitted to age-specific rates by 5-year age groups against observed years based on observed cancer incidence data of the latest trend. Finally, we multiply the projected age-specific rates by the age-specific population to get the projected cancer cases and deaths of the year 2019. For thyroid cancer, we used a square root transformation when fitting a linear regression model and converted the predicted values back to the original scale.

We summarized the results by using crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. ASRs were standardized using the world standard population \[[@b8-crt-2019-139]\] and expressed per 100,000 persons.

Results
=======

1. Incidence
------------

A total of 221,347 new cancer cases are anticipated in 2019 ([Table 1](#t1-crt-2019-139){ref-type="table"}, [Fig. 1](#f1-crt-2019-139){ref-type="fig"}), and more males (n=120,352) than females (n=100,995) are expected to be affected.

The projected CRs per 100,000 of all sites combined in 2019 are expected to be 463.5 and 390.8 in men and women, respectively ([Table 2](#t2-crt-2019-139){ref-type="table"}). The projected ASRs per 100,000 of all sites combined is 264.1 and 215.4 for men and women, respectively. In men, the five leading primary sites of cancer are expected to be the lung (CR, 75.9; ASR, 40.3), stomach (CR, 69.5; ASR, 38.8), colon and rectum (CR, 55.8; ASR, 30.9), prostate (CR, 51.3; ASR, 27.4), and liver (CR, 43.5; ASR, 24.3), accounting for 63.8% of all new cancers in 2019.

In women, the five leading primary sites are expected to be the breast (CR, 92.9; ASR, 58.4), colon and rectum (CR, 42.0; ASR, 18.4), stomach (CR, 35.4; ASR, 16.9), thyroid (CR, 32.9; ASR, 25.8), and lung (CR, 32.5; ASR, 14.8), accounting for 60.3% of all new cancers ([Fig. 1](#f1-crt-2019-139){ref-type="fig"}).

The five most common cancer sites expected in 2019 by sex and age groups are shown in [Table 3](#t3-crt-2019-139){ref-type="table"}. Leukemia and thyroid cancer are expected to be the most common forms of cancer in both sexes for the 0-14 and 15-34 age groups. Stomach cancer is predicted to be the most prevalent cancer in men aged 35-64 years, while lung cancer is expected to be more frequent in men aged 65 years and above. Breast cancer is predicted to be the most common cancer in women aged 35-64 years, whereas colorectal cancer is expected to be the most prevalent in women aged 65 years and above. These projections indicate that the incidences of stomach, lung, liver, colorectal and prostate cancers will increase gradually with age for men ([Fig. 2](#f2-crt-2019-139){ref-type="fig"}). In women, the age-specific incidence rates of stomach, colorectal, liver, lung, and cervical cancers denote a rising trend in these cancers with age; however, the incidence of breast and thyroid cancers in women is expected to level off after the age of 40.

2. Mortality
------------

It is estimated that 82,344 cancer deaths will occur in Korea during 2019 ([Table 1](#t1-crt-2019-139){ref-type="table"}, [Fig. 1](#f1-crt-2019-139){ref-type="fig"}). The projected CRs per 100,000 of all sites combined in 2019 for men and women are projected to be 193.9 and 123.8, respectively, whereas the projected ASRs per 100,000 of all sites combined are expected to be 102.7 and 49.4, respectively ([Table 4](#t4-crt-2019-139){ref-type="table"}). The predicted five leading cancer sites causing mortality in men are predicted to be lung (CR, 54.9; ASR, 28.0), liver (CR, 30.1; ASR, 16.3), colon and rectum (CR, 18.5; ASR, 9.8), stomach (CR, 16.8 ASR, 8.9), and pancreas (CR, 13.0; ASR, 7.0). During the same period, lung cancer (CR, 20.3; ASR, 7.5) is projected to be the leading cancer cause of death in women, followed by the colon and rectum (CR, 14.9; ASR, 5.2), pancreas (CR, 12.5; ASR, 4.7), liver (CR, 11.2; ASR, 4.2), and breast (CR, 10.5; ASR, 5.7).

The predicted age-specific mortality rates of the selected cancers for males and females in 2019 are shown in further detail in [Fig. 3](#f3-crt-2019-139){ref-type="fig"}. When examined by age, Korean men and women aged 60 years and above are expected to have the highest mortality rates from lung cancer.

Conclusion
==========

A total of 221,347 new cancer cases and 82,344 cancer deaths are expected to occur in Korea during 2019. Lung cancer is predicted to the most common cancer among males, followed by stomach, colorectal, prostate, and liver cancers. Lung, liver, colorectal, stomach, and pancreatic cancers are expected to be the most common causes of cancer deaths among men. In women, the five leading primary sites are expected to be the breast, colorectal, stomach, thyroid, and lung cancers, while lung, colorectal, pancreatic, liver, and breast cancers are projected to be the most common causes of cancer-related deaths.

Cancer is currently one of the foremost public health concerns in Korea. Although cancer rates are anticipated to decrease somewhat, but burden of most of cancers will continue to grow with the increasing age of the population. The current projections of cancer incidence and mortality for 2019 represent an important resource for planning and evaluating cancer-control programs. As the estimates in this study are model-based, these results should be interpreted with caution. Specifically, the incidence of some cancers, such as stomach, colorectum, and thyroid cancers, started to decrease from early 2010s; thus, recent trends of these cancers contained only 5 or 6 data points for analysis, and therefore, their estimates could be unstable.
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###### 

Estimated new cancer cases and deaths by sex during 2019 in Korea

  Site                                                         Estimated new cases   Estimated deaths                               
  ------------------------------------------------------------ --------------------- ------------------ --------- -------- -------- --------
  All sites                                                    221,347               120,352            100,995   82,344   50,352   31,992
  Lip, oral cavity, and pharynx                                3,789                 2,736              1,053     1,221    897      324
  Esophagus                                                    2,548                 2,318              230       1,321    1,173    148
  Stomach                                                      27,175                18,039             9,136     6,729    4,349    2,380
  Colon and rectum                                             25,330                14,478             10,852    8,653    4,813    3,840
  Liver^[a)](#tfn1-crt-2019-139){ref-type="table-fn"}^         15,016                11,281             3,735     10,720   7,824    2,896
  Gallbladder^[b)](#tfn2-crt-2019-139){ref-type="table-fn"}^   7,677                 4,081              3,596     4,750    2,353    2,397
  Pancreas                                                     7,927                 4,135              3,792     6,609    3,380    3,229
  Larynx                                                       1,095                 1,035              60        292      292      0
  Lung^[c)](#tfn3-crt-2019-139){ref-type="table-fn"}^          28,107                19,700             8,407     19,488   14,254   5,234
  Breast                                                       24,100                90                 24,010    2,727    21       2,706
  Cervix uteri                                                 2,856                 \-                 2,856     834      \-       834
  Corpus uteri                                                 3,061                 \-                 3,061     372      \-       372
  Ovary                                                        2,832                 \-                 2,832     1,271    \-       1,271
  Prostate                                                     13,326                13,326             \-        2,281    2,281    \-
  Testis                                                       313                   313                \-        18       18       \-
  Kidney                                                       5,609                 3,794              1,815     1,189    816      373
  Bladder                                                      4,721                 3,745              976       1,610    1,216    394
  Brain and CNS                                                2,087                 1,123              964       1,332    694      638
  Thyroid                                                      11,667                3,163              8,504     340      92       248
  Hodgkin lymphoma                                             340                   217                123       61       40       21
  Non-Hodgkin lymphoma                                         5,264                 3,046              2,218     2,051    1,182    869
  Multiple myeloma                                             1,944                 1,049              895       1,140    615      525
  Leukemia                                                     3,683                 2,123              1,560     1,935    1,093    842
  Other and ill defined                                        20,880                10,560             10,320    5,400    2,949    2,451

CNS, central nervous system.

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the trachea, bronchus, and lung.

###### 

Estimated crude and age-standardized cancer incidences by sex during 2019 in Korea

  Site                                                         Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000^[a)](#tfn4-crt-2019-139){ref-type="table-fn"}^                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    427.2                              463.5                                                                                        390.8   233.5   264.1   215.4
  Lip, oral cavity, and pharynx                                7.3                                10.5                                                                                         4.1     4.2     6.2     2.4
  Esophagus                                                    4.9                                8.9                                                                                          0.9     2.4     4.8     0.4
  Stomach                                                      52.5                               69.5                                                                                         35.4    27.1    38.8    16.9
  Colon and rectum                                             48.9                               55.8                                                                                         42.0    24.2    30.9    18.4
  Liver^[b)](#tfn5-crt-2019-139){ref-type="table-fn"}^         29.0                               43.5                                                                                         14.5    14.8    24.3    6.4
  Gallbladder^[c)](#tfn6-crt-2019-139){ref-type="table-fn"}^   14.8                               15.7                                                                                         13.9    6.7     8.4     5.4
  Pancreas                                                     15.3                               15.9                                                                                         14.7    7.3     8.7     6.1
  Larynx                                                       2.1                                4.0                                                                                          0.2     1.1     2.1     0.1
  Lung^[d)](#tfn7-crt-2019-139){ref-type="table-fn"}^          54.3                               75.9                                                                                         32.5    25.9    40.3    14.8
  Breast                                                       46.5                               0.4                                                                                          92.9    29.3    0.2     58.4
  Cervix uteri                                                 5.5                                0.0                                                                                          11.1    3.5     \-      6.9
  Corpus uteri                                                 5.9                                0.0                                                                                          11.8    3.6     \-      7.2
  Ovary                                                        5.5                                0.0                                                                                          11.0    3.4     \-      6.8
  Prostate                                                     25.7                               51.3                                                                                         0.0     12.4    27.4    \-
  Testis                                                       0.6                                1.2                                                                                          0.0     0.6     1.2     \-
  Kidney                                                       10.8                               14.6                                                                                         7.0     6.2     8.8     3.8
  Bladder                                                      9.1                                14.4                                                                                         3.8     4.3     7.7     1.6
  Brain and CNS                                                4.0                                4.3                                                                                          3.7     3.0     3.4     2.6
  Thyroid                                                      22.5                               12.2                                                                                         32.9    17.2    9.0     25.8
  Hodgkin lymphoma                                             0.7                                0.8                                                                                          0.5     0.6     0.7     0.4
  Non-Hodgkin lymphoma                                         10.2                               11.7                                                                                         8.6     6.3     7.8     5.0
  Multiple myeloma                                             3.8                                4.0                                                                                          3.5     1.9     2.2     1.6
  Leukemia                                                     7.1                                8.2                                                                                          6.0     5.5     6.5     4.6
  Other and ill defined                                        40.3                               40.7                                                                                         39.9    22.1    24.8    19.7

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the trachea, bronchus, and lung.

###### 

Estimated cancer incidence by age group and sex during 2019 in Korea

  Rank         Age group (yr)                                                                                                                                          
  ------------ ------------------------------------------------------------ ---------------------------- ------------------------------------------------------------- --------------------------------------------------------------------
  **Male**                                                                                                                                                             
   1           Leukemia (5.0)                                               Thyroid (10.7)               Stomach (68.3)                                                Lung^[a)](#tfn8-crt-2019-139){ref-type="table-fn"}^ (429.8)
   2           Non-Hodgkin lymphoma (3.1)                                   Leukemia (3.7)               Colon and rectum (47.6)                                       Prostate (306.0)
   3           Brain and CNS (2.3)                                          Non-Hodgkin lymphoma (3.2)   Liver^[a)](#tfn8-crt-2019-139){ref-type="table-fn"}^ (47.0)   Stomach (287.8)
   4           Kidney (0.4)                                                 Testis (2.7)                 Lung (43.8)                                                   Colon and rectum (254.4)
   5           Liver^[b)](#tfn9-crt-2019-139){ref-type="table-fn"}^ (0.4)   Colon and rectum (2.3)       Prostate (25.9)                                               Liver^[a)](#tfn8-crt-2019-139){ref-type="table-fn"}^ (163.1)
  **Female**                                                                                                                                                           
   1           Leukemia (4.3)                                               Thyroid (32.9)               Breast (157.2)                                                Colon and rectum (162.5)
   2           Brain and CNS (1.9)                                          Breast (11.9)                Thyroid (45.9)                                                Lung^[b)](#tfn9-crt-2019-139){ref-type="table-fn"}^ (119.5)
   3           Non-Hodgkin lymphoma (1.7)                                   Cervix uteri (5.7)           Stomach (31.3)                                                Stomach (118.8)
   4           Ovary (0.7)                                                  Ovary (3.3)                  Colon and rectum (29.7)                                       Breast (95.1)
   5           Kidney (0.4)                                                 Leukemia (2.4)               Lung^[b)](#tfn9-crt-2019-139){ref-type="table-fn"}^ (25.4)    Gallbladder^[c)](#tfn10-crt-2019-139){ref-type="table-fn"}^ (64.5)

CNS, central nervous system.

Includes the trachea, bronchus, and lung,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Estimated crude and age-standardized cancer mortality rates by sex during 2019 in Korea

  Site                                                          Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000^[a)](#tfn11-crt-2019-139){ref-type="table-fn"}^                          
  ------------------------------------------------------------- ---------------------------------- --------------------------------------------------------------------------------------------- ------- ------ ------- ------
  All sites                                                     158.9                              193.9                                                                                         123.8   71.9   102.7   49.4
  Lip, oral cavity, and pharynx                                 2.4                                3.5                                                                                           1.3     1.1    1.9     0.5
  Esophagus                                                     2.6                                4.5                                                                                           0.6     1.1    2.3     0.2
  Stomach                                                       13.0                               16.8                                                                                          9.2     5.7    8.9     3.3
  Colon and rectum                                              16.7                               18.5                                                                                          14.9    7.3    9.8     5.2
  Liver^[b)](#tfn12-crt-2019-139){ref-type="table-fn"}^         20.7                               30.1                                                                                          11.2    9.8    16.3    4.2
  Gallbladder^[c)](#tfn13-crt-2019-139){ref-type="table-fn"}^   9.2                                9.1                                                                                           9.3     3.7    4.6     3.1
  Pancreas                                                      12.8                               13.0                                                                                          12.5    5.8    7.0     4.7
  Larynx                                                        0.6                                1.1                                                                                           0.0     0.2    0.6     0.0
  Lung^[d)](#tfn14-crt-2019-139){ref-type="table-fn"}^          37.6                               54.9                                                                                          20.3    16.2   28.0    7.5
  Breast                                                        5.3                                0.1                                                                                           10.5    3.0    0.0     5.7
  Cervix uteri                                                  1.6                                \-                                                                                            3.2     0.8    \-      1.6
  Corpus uteri                                                  0.7                                \-                                                                                            1.4     0.4    \-      0.7
  Ovary                                                         2.5                                \-                                                                                            4.9     1.3    \-      2.4
  Prostate                                                      4.4                                8.8                                                                                           \-      1.7    4.5     \-
  Testis                                                        0.0                                0.1                                                                                           \-      0.0    0.1     \-
  Kidney                                                        2.3                                3.1                                                                                           1.4     1.1    1.7     0.6
  Bladder                                                       3.1                                4.7                                                                                           1.5     1.2    2.4     0.5
  Brain and CNS                                                 2.6                                2.7                                                                                           2.5     1.6    1.8     1.4
  Thyroid                                                       0.7                                0.4                                                                                           1.0     0.3    0.2     0.3
  Hodgkin lymphoma                                              0.1                                0.2                                                                                           0.1     0.1    0.1     0.0
  Non-Hodgkin lymphoma                                          4.0                                4.6                                                                                           3.4     1.8    2.5     1.3
  Multiple myeloma                                              2.2                                2.4                                                                                           2.0     1.0    1.3     0.8
  Leukemia                                                      3.7                                4.2                                                                                           3.3     2.0    2.6     1.6
  Other and ill defined                                         10.4                               11.4                                                                                          9.5     4.9    6.3     3.8

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the trachea, bronchus, and lung.
